Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason P Sinnwell

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|October 24, 2020
Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and UptakeJulian O Kim, Daniel J Schaid, Celine M Vachon, et al.
BMC Bioinformatics|April 18, 2018
Identification of missing variants by combining multiple analytic pipelinesYingxue Ren, Joseph S Reddy, Cyril Pottier, et al.
Clinical Pharmacology and Therapeutics|March 15, 2022
Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration-Resistant Prostate CancerSisi Qin, Huanyao Gao, Wootae Kim, et al.
Plos One|April 16, 2021
Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studiesDaniel P Wickland, Yingxue Ren, Jason P Sinnwell, et al.
Molecular Cancer Research : MCR|September 22, 2022
Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone TreatmentHugues Sicotte, Krishna R Kalari, Sisi Qin, et al.
Breast Cancer Research : BCR|May 24, 2023
Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumorsXiaojia Tang, Kevin J Thompson, Krishna R Kalari, et al.
NPJ Breast Cancer|March 30, 2024
Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancerRoberto A Leon-Ferre, Jodi M Carter, David Zahrieh, et al.
The Pharmacogenomics Journal|October 21, 2021
Nine-gene pharmacogenomics profile service: The Mayo Clinic experienceEric T Matey, Ashley Kate Ragan, Lance J Oyen, et al.
Pharmacogenetics and Genomics|June 19, 2019
Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancerJames N Ingle, Krishna R Kalari, Yukihide Momozawa, et al.
BMJ Open|April 17, 2016
Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancerSteven N Hart, Marissa S Ellingson, Kim Schahl, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Cancer Prevention Research (Philadelphia, Pa.)|October 24, 2020
Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and UptakeJulian O Kim, Daniel J Schaid, Celine M Vachon, et al.
BMC Bioinformatics|April 18, 2018
Identification of missing variants by combining multiple analytic pipelinesYingxue Ren, Joseph S Reddy, Cyril Pottier, et al.
Clinical Pharmacology and Therapeutics|March 15, 2022
Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration-Resistant Prostate CancerSisi Qin, Huanyao Gao, Wootae Kim, et al.
Plos One|April 16, 2021
Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studiesDaniel P Wickland, Yingxue Ren, Jason P Sinnwell, et al.
Molecular Cancer Research : MCR|September 22, 2022
Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone TreatmentHugues Sicotte, Krishna R Kalari, Sisi Qin, et al.
Breast Cancer Research : BCR|May 24, 2023
Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumorsXiaojia Tang, Kevin J Thompson, Krishna R Kalari, et al.
NPJ Breast Cancer|March 30, 2024
Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancerRoberto A Leon-Ferre, Jodi M Carter, David Zahrieh, et al.
The Pharmacogenomics Journal|October 21, 2021
Nine-gene pharmacogenomics profile service: The Mayo Clinic experienceEric T Matey, Ashley Kate Ragan, Lance J Oyen, et al.
Pharmacogenetics and Genomics|June 19, 2019
Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancerJames N Ingle, Krishna R Kalari, Yukihide Momozawa, et al.
BMJ Open|April 17, 2016
Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancerSteven N Hart, Marissa S Ellingson, Kim Schahl, et al.
Pageof 6